Researchers are testing an unconventional way to treat amblyopia, better known as “lazy eye,” by briefly shutting the weaker ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

About 69% of pediatric patients had discontinued amblyopia therapy during COVID-19 even as their parents reported that adherence was good. Although parents reported good adherence to therapy, a new ...

Crunchyroll, the global brand fueling anime fandom, is now part of an FDA-approved and doctor-prescribed VR treatment for kids with lazy eye. Through a new collaboration with digital health company ...

Massachusetts-based Luminopia landed an FDA De Novo for its virtual reality digital therapeutic focused on helping children improve amblyopia, commonly called lazy eye. The therapy, called Luminopia ...

FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy eye in children AIRPORT CITY, ISRAEL / ACCESS Newswire / April 21, 2025 / ...

CAMBRIDGE, Mass., Oct. 28, 2025 /PRNewswire/ -- Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced a collaboration with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Luminopia One, an investigational digital therapy that ...

The FDA has granted de novo premarket approval for Luminopia One, a digital therapy for children aged 4 to 7 years with amblyopia, according to a press release from Luminopia. The therapy, which ...

SAN FRANCISCO, Aug. 27, 2019 (GLOBE NEWSWIRE) -- AmblyoPlay, a home-based vision therapy solution for children and adults with amblyopia (lazy eye), mild strabismus (crossed or turned eye) or ...